Home / News / States To Test Monoclonal Mntibodies Against COVID-19

States To Test Monoclonal Mntibodies Against COVID-19

Research teams around the world are looking for a cure for the new coronavirus. As reported by Mirage News , the US is ready to test a drug based on monoclonal antibodies. These elements are designed to provide an immediate antiviral effect that lasts several weeks.

The trials are involving 220 people across the country – the first half will receive a placebo and the other half will receive a drug known as LY3819253. This is an experimental monoclonal antibody therapy developed by Lilly Research Laboratories in partnership with AbCellera Biologics.

Known: AbCellera and the National Institute of Allergy and Infectious Diseases identified antibodies in a blood sample from one of the first people in the United States to recover from COVID-19. Using these antibodies, monoclonal antibodies were generated. These are antibodies produced by immune cells belonging to the same cell clone (derived from a single plasma progenitor cell).

The aim of the new study is to test the safety and antiviral activity of a drug based on monoclonal antibodies. The drug LY3819253 was selected based on data demonstrating its activity against SARS-CoV-2 in laboratory studies, as well as based on pharmacokinetic and safety data of the first phase of trials, which included about 400 people.

About admin

Check Also

The USA Showed How to Destroy the Russian anti-aircraft Systems S-400

Lockheed-Martin, the main arms supplier for the Pentagon, has unveiled a new guided missile. A …